Showing results (1-10 of 1,403) with videos related to
Sort By:
Pageof 141
NPJ Parkinson'S Disease|November 23, 2022
Dose-response meta-analysis on urate, gout, and the risk for Parkinson's diseaseHongtao Chang, Benqiao Wang, Yue Shi, et al.NPJ Parkinson'S Disease|October 21, 2020
Extradural Motor Cortex Stimulation might improve episodic and working memory in patients with Parkinson's diseaseCarla Piano, Marco Ciavarro, Francesco Bove, et al.NPJ Parkinson'S Disease|July 16, 2021
Longitudinal evolution of non-motor symptoms in early Parkinson's disease: a 3-year prospective cohort studyRuwei Ou, Yanbing Hou, Qianqian Wei, et al.NPJ Parkinson'S Disease|July 9, 2021
Parkinson's disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRIFrédérique Depierreux, Eric Parmentier, Laurane Mackels, et al.NPJ Parkinson'S Disease|June 20, 2022
Cognition as a mediator for gait and balance impairments in GBA-related Parkinson's diseaseRosie Morris, Douglas N Martini, Katrina Ramsey, et al.NPJ Parkinson'S Disease|December 22, 2022
Genetically engineered mesenchymal stem cells with dopamine synthesis for Parkinson's disease in animal modelsJun Li, Nan Li, Jingkuan Wei, et al.NPJ Parkinson'S Disease|January 7, 2023
C/EBPβ/AEP is age-dependently activated in Parkinson's disease and mediates α-synuclein in the gut and brainHualong Wang, Guiqin Chen, Eun Hee Ahn, et al.NPJ Parkinson'S Disease|December 29, 2022
Baseline cerebral structural morphology predict freezing of gait in early drug-naïve Parkinson's diseaseYuting Li, Xiaofei Huang, Xiuhang Ruan, et al.NPJ Parkinson'S Disease|December 19, 2022
Optical pulse labeling studies reveal exogenous seeding slows α-synuclein clearanceCara L Croft, Giavanna Paterno, Ava R Vause, et al.NPJ Parkinson'S Disease|June 13, 2022
Effects of MAO-B inhibitors on non-motor symptoms and quality of life in Parkinson's disease: A systematic reviewTakashi Tsuboi, Yuki Satake, Keita Hiraga, et al.Pageof 141